Justiss Kallos
Papers
1
Total Citations
7
H-Index
1
About
Justiss Kallos is a clinical researcher whose work centers on neurorehabilitation and the pharmacological enhancement of recovery after neurological injury. Their most notable contribution is a pioneering randomized, placebo-controlled, double-blind pilot study investigating D-Cycloserine as a therapeutic agent in chronic stroke patients. This work directly addresses a critical gap in stroke care: the fact that up to 60% of patients fail to achieve full recovery despite intensive physical therapy. By targeting N-Methyl-D-aspartate receptors (NMDA-R), which are essential for synaptic plasticity, Kallos explored a novel mechanism to augment motor learning and neural repair. Although the study has garnered 7 citations to date, its significance lies in its foundational role for future research into NMDA receptor modulation in post-stroke rehabilitation. Kallos’s work bridges neurology and pharmacology, offering a promising pathway for improving functional outcomes in chronic stroke survivors. Their research is particularly relevant for students and clinicians interested in translational neuroscience and the development of adjuvant therapies for neurorehabilitation.
Research Focus
Key Achievements
Top Papers
- 1